Form D · Venture Capital Fund
Summit Life Sciences LP
Draper, UT · CIK 0001475827
Offering snapshot reported Nov 5, 2009 · SEC filing
- Reported sold
- $25M Offering amount: $100M
- Investors reported
- 2 Form D · investor count
- Minimum accepted
- $0 Reported outside-investor minimum
- First sale
- Oct 26, 2009 As reported in this filing
What changed?
Latest filing versus its linked predecessor, where available.
No comparable changes in the displayed metrics.
Filing history
Scroll to see all columns →
| Filed | Filing type | Reported sold | Change vs linked filing | Investors | Source |
|---|---|---|---|---|---|
| Nov 5, 2009 | Initial | $25,000,000 | No comparison | 2 | SEC filing |
Offering details
- Securities
- Not reported
- Exemptions
- 06, 3C, 3C.7
- Duration over one year
- No
- Business combination
- No
- Sales commissions
- $0
- Finders' fees
- $0
- Form D file number
- 021-135897
Source: Form D, filed Nov 5, 2009. Minimum accepted may differ from a standard advertised minimum.
Fund connections
No confirmed ADV fund connection is available for this issuer.
People & organizations
Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.
| Name | Reported role |
|---|---|
| Shawn Fojtik | Director, Executive |
| Robert Mitchell | Director, Executive |
| Jeffrey S Smith | Director, Executive |
| Summit Life Sciences Partners Llc | Promoter |
Issuer details
Industry: Pooled Investment Fund (See others in industry)
Address:
13512 Aintree Avenue
Draper, UT, 84020
Draper, UT, 84020